Your browser doesn't support javascript.
loading
Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.
Bezerra, Matheus F; Lima, Aleide S; Piqué-Borràs, Maria-Riera; Silveira, Douglas R; Coelho-Silva, Juan L; Pereira-Martins, Diego A; Weinhäuser, Isabel; Franca-Neto, Pedro L; Quek, Lynn; Corby, Anna; Oliveira, Mayara M; Lima, Marinus M; de Assis, Reijane A; de Melo Campos, Paula; Duarte, Bruno K; Bendit, Israel; Rocha, Vanderson; Rego, Eduardo M; Traina, Fabiola; Saad, Sara T; Beltrão, Eduardo I; Bezerra, Marcos A; Lucena-Araujo, Antonio R.
Affiliation
  • Bezerra MF; Keizo Asami Immunopathology Laboratory, Federal University of Pernambuco, Recife, Brazil.
  • Lima AS; Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil.
  • Piqué-Borràs MR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • Silveira DR; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Coelho-Silva JL; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.
  • Pereira-Martins DA; Hematology Department, AC Camargo Cancer Center, São Paulo, Brazil.
  • Weinhäuser I; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • Franca-Neto PL; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Quek L; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • Corby A; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Oliveira MM; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil.
  • Lima MM; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • de Assis RA; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.
  • de Melo Campos P; Medical Research Council (MRC) Molecular Hematology Unit, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom.
  • Duarte BK; Medical Research Council (MRC) Molecular Hematology Unit, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom.
  • Bendit I; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • Rocha V; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
  • Rego EM; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.
  • Traina F; Hematology and Transfusion Medicine Center and.
  • Saad ST; Hematology and Transfusion Medicine Center and.
  • Beltrão EI; Department of Internal Medicine, University of Campinas, Campinas, São Paulo, Brazil; and.
  • Bezerra MA; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.
  • Lucena-Araujo AR; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.
Blood ; 135(11): 870-875, 2020 03 12.
Article in En | MEDLINE | ID: mdl-31977039

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Biomarkers, Tumor / DNA (Cytosine-5-)-Methyltransferases / Fms-Like Tyrosine Kinase 3 Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Biomarkers, Tumor / DNA (Cytosine-5-)-Methyltransferases / Fms-Like Tyrosine Kinase 3 Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: Country of publication: